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Abstract
Spectrin is a central component of the cytoskeletal protein network in a variety of erythroid and non-erythroid cells. In
keratinocytes, this protein has been shown to be pericytoplasmic and plasma membrane associated, but its characteristics
and function have not been established in these cells. Here we demonstrate that spectrin increases dramatically in amount
and is assembled into the cytoskeleton during differentiation in mouse and human keratinocytes. The spectrin-like
cytoskeleton was predominantly organized in the granular and cornified layers of the epidermis and disrupted by actin
filament inhibitors, but not by anti-mitotic drugs. When the cytoskeleton was disrupted PKCd was activated by
phosphorylation on Thr505. Specific inhibition of PKCd
(Thr505) activation with rottlerin prevented disruption of the spectrin-
like cytoskeleton and the associated morphological changes that accompany differentiation. Rottlerin also inhibited specific
phosphorylation of the PKCd substrate adducin, a cytoskeletal protein. Furthermore, knock-down of endogenous adducin
affected not only expression of adducin, but also spectrin and PKCd, and severely disrupted organization of the spectrin-like
cytoskeleton and cytoskeletal distribution of both adducin and PKCd. These results demonstrate that organization of a
spectrin-like cytoskeleton is associated with keratinocytes differentiation, and disruption of this cytoskeleton is mediated by
either PKCd
(Thr505) phosphorylation associated with phosphorylated adducin or due to reduction of endogenous adducin,
which normally connects and stabilizes the spectrin-actin complex.
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Introduction
Spectrin is a high molecular weight protein, with a wide range
of physiological functions [1,2]. This protein comprises a
(240 kDa) and b (220 kDa) subunits, which associate to form an
elongated (ab)2 tetramer [1]. Located close to the interior surface
of the plasma membrane, spectrin forms a hexagonal lattice, the
nodes of which are cross-linked by the cytoskeletal protein actin
[1]. Spectrin was first identified as a central component of the
cytoskeletal protein network [3], and was thought to be
erythrocyte-specific [4,5]. The identification of a non-erythroid
spectrin-like protein [6] was followed by the widespread discovery
of avian spectrin in non-erythroid cells [7,8]. Spectrin plays a wide
variety of functions including axonal transport, neurite extension
and protein sorting in the Golgi apparatus and cell membrane in
erythrocytes. This protein also enables red blood cells to pass
through capillaries, confers elasticity on the cell, maintains the
discoid shape of the membrane and organization of synaptic
vesicles and restricts the lateral mobility of its macromolecules [9].
However, whether spectrin has the same functions in non-
erythrocytes remained unknown over two decades [1]. Further
studies in C. elegans proved that b -spectrin is required for a subset
of processes at cell membranes [10,11]. The loss of b -spectrin
leads to abnormal axon outgrowth in neurons, to disorganization
of the myofilament lattice, discontinuities in the dense bodies, and
a reduction or loss of the sarcoplasmic reticulum in muscles
[10,11]. Genetic analysis in Drosophila provides evidence that b-
spectrin mutations are lethal during late embryonic/early larval
development and this protein plays a role in determining the
subcellular distribution of the Na
+,K
+ ATPase [12].
Keratinocytes are the major cell type in the epidermis
responsible for constructing the protective barrier of mammalian
skin by undergoing a complex and carefully choreographed
program of cell differentiation [13]. Proliferative keratinocytes in
the basal layer periodically detach from an underlying basement
membrane of extracellular matrix and move outward. Once in the
suprabasal layer, keratinocytes stop dividing and enter a
differentiation program. Terminally differentiated keratinocytes
flatten and develop the cornified envelopes, which consist of a
stabilized array of keratin filaments contained within a covalently
cross-linked protein envelope and play a critical protection role in
barrier function of the epithelium [14]. Without this protection,
the epithelium would quickly hydrate in wet environments,
dehydrate in arid environment and be extremely susceptible to
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importance of this barrier for survival is the heroic efforts required
to assist burn victims in regulating fluid balance and remaining
free of infection [15]. In keratinocytes, non-erythrocyte spectrin is
pericytoplasmic and plasma membrane-associated [17,18]. How-
ever, to date, the characteristics and function of the spectrin-like
cytoskeleton in keratinocytes are not well understood. Here, we
studied spectrin protein expression and organization of the
spectrin-like cytoskeleton in both mouse and human keratinocytes
in vitro and in vivo. We showed that this membrane-bound protein
expression and its cytoskeletal organization were associated with
keratinocyte differentiation. We also showed that the spectrin-like
cytoskeleton in differentiating keratinocytes in vitro was disrupted
by actin microfilament inhibitors and by b-adducin siRNA. We
demonstrated that disruption of the spectrin-like cytoskeleton
associated with keratinocyte differentiation and cellular integrity
was mediated through PKCd activation associated with phos-
phorylation of adducin or expression of endogenous adducin.
Methods
Antibodies
Primary antibodies (Abs) used were rabbit polyclonal Abs to
human spectrin (S1515) and to actin; mouse monoclonal Abs to b-
tubulin and to protein kinase C (PKC). All were from Sigma-
Aldrich (Australia). Rabbit polyclonal antibodies to involucrin and
K14 were purchased from Covance (USA). Mouse monoclonal Ab
to aI spectrin, rabbit polyclonal antibodies to PKCd, to adducin b
and p-adducin
(Ser662) and goat polyclonal antibodies to bI spectrin
and p-PKCd
(Thr505) were purchased from St Cruz (USA). Rabbit
polyclonal antibodies to PKCa, p-PKCa
(Ser 657) and p-
PKCa
(Thr638/641) were purchased from Cell Signalling (USA).
Primary keratinocyte culture
Primary keratinocytes were isolated from new born mouse skin
as previously described [19]. Isolated keratinocytes were grown as
adherent cultures in a freshly prepared medium (365 ml DMEM
medium, 2 mM glutamine, 100 unit/ml penicillin, 100 unit/ml
streptomycin, 125 ml Hams F12 medium, 50 ml FBS, 2.5 mg
transferrin, 2.5 mg insulin, 4.2 mg cholera toxin, 0.12 mg
hydrocortisone, 17 mg adenine and 10 mg gentamicin) for one
day (D1) and then cultured in KC-SFM medium with low
concentration of calcium (0.2 mM) (GIBCO, Australia) for three
(D4) and six (D7) days. This low concentration of calcium could
induce the keratinocytes commitment to terminal differentiation
within a week based on our previous studies [19,20]. The cultured
keratinocytes at three time points (D1, D4 and D7) were collected
for examining spectrin expression and organization of spectrin-like
cytoskeleton.
Inhibitor treatments
(A). Treatment with anti-mitotic drugs and microfilament
inhibitors. Primary keratinocytes grown in vitro for five days were
treated with two anti-mitotic drugs (3 mM nocodazole (Noc) and
3 mM colchicines (Col)) and three microfilament inhibitors (4 mM
cytochalasin B (CB), 1.2 mM staurosporine (STS) and 1.2 mM
latrunculin B [21]) for 12 h. (B). Co-treatment with rottlerin (RT)
and microfilament inhibitors. Primary keratinocytes grown in vitro
for five days were treated either with RT (2 mM) and three
microfilament inhibitors (4 mM CB, 1.2 mM STS and 1.2 mM Lat)
alone; or co-treated with RT and one of three microfilament
inhibitors respectively for 12 h. The inhibitor-treated keratinocytes
were fixed for immunofluorescence microscopy and collected for
protein preparation for Western blotting.
b-Adducin siRNA transfection
One control siRNA(SC-37007; St Cruz, USA) and one b-
adducin siRNA that consist of pools of three to five target-specific
19–25 nt siRNAs designed to knockdown gene expression (SC-
37061, St Cruz, USA) were used for knock-down of endogenous
adducin expression in primary mouse keratinocytes. The primary
mouse keratinocyte culture at D5 with 80% confluence were
transfected with the two mouse siRNAs using siRNA transfection
reagents (St Cruz, USA) following the manufacturer’s directions.
siRNA transfected-keratinocytes were either harvested for prepa-
ration of protein samples, or fixed for immunofluorescence
labeling at 48 h post- transfection.
Immunofluorescence labelling
Keratinocytes cultured for one, four and seven days were fixed
and permeabilized with 85% ethanol for 10 min. Fixed keratino-
cytes were blocked with 5% skim milk-PBST and probed with a
polyclonal antibody against ab-spectrin (Sigma) followed by a
fluorescein-isothiocyanate-conjugated (FITC) secondary antibody
(Sigma). The spectrin labelled keratinocytes were further probed
with Cy3-conjugated monoclonal antibody against tubulin (Sigma)
or with a polyclonal antibody against involucrin (Covance, USA)
and followed by a Cy3-conjugated secondary antibody (Sigma).
Nuclei were counterstained with 49,6 9-diamidino-2-phenylindole
(DAPI). Immunofluorescence labelling was similarly performed on
paraffin sections of mouse skin and human foreskin using a
polyclonal antibody against ab-spectrin (Sigma, Australia) and
followed by a FITC secondary antibody. The spectrin labelled skin
sections were further blocked with 5% skim milk-PBS and probed
with Cy3-conjugated monoclonal antibody against tubulin (Sig-
ma), or with a polyclonal antibody against keratin K14 (Covance,
USA), and or with a polyclonal antibody against involucrin
(Covance, USA) and followed by Cy3-conjugated secondary
antibody (Sigma). Nuclei were counterstained with DAPI.
Fluorescent staining was photographed using a Zess Eclipse 800
microscope equipped with a DXM1200 digital camera.
Western blot analysis
Cultured primary mouse and human keratinocytes were
collected for protein preparation. Cell pellets were lysed in lysis
buffer, pH 7.4, containing 2 mM phenylmethylsulfonyl fluoride
(PMSF), 2 mg/ml of aprotinin; 2 mg/ml of benzamidine (Sigma)
and 1 mg/ml of leupeptin (Auspep, Australia) and sonicated for
40 sec. Forty mg protein samples were separated by 6%
polyacrylamide gel and blotted onto PVDF membrane. The blots
were first probed with either polyclonal antibodies against ab-
spectrin, or involucrin, or PKCd, P-PKCd, or adducin and P-
adducin, or actin, and or a monoclonal antibody against b-tubulin.
The blots were then probed with horseradish-peroxidase-conju-
gated goat anti-rabbit or mouse IgG (Sigma) and visualized using a
chemiluminescence system. Alternatively, the blots were first
probed with the polyclonal antibodies against either ab-spectrin or
a- and b-spectrin in Odssey blocking buffer. The blots were then
probed with secondary donkey anti-rabbit antibody (IRDyeH680,
Odyssey) and visualized using an Odyssey infrared imaging
system.
Immunoprecipitation
Keratinocytes, after washing with phosphate-buffered saline,
lysing in 1 ml of lysis buffer (50 mM Tris-HCl, pH 8, containing
150 mM NaCl, 1% NP-40, 1 mM MgCl2, 1 mM EDTA, 2 mM
PMSF, 2 mg/ml leupeptin, 2 mg/ml aprotinin and 1 mg/ml
pepstatin) were sonicated and centrifuged at 12,000 g at 4uC for
Spectrin in Keratinocyte
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protein G beads, previously washed with 500 ml of lysis buffer for
1 h at 4uC. Antibodies either monoclonal or polyclonal against
different target proteins were added to the precleared supernatant,
respectively, with 1.5 mg of antibody to 400 mg of protein. The
protein sample with antibody was incubated for 2 h at 4uC with
gentle agitation. The complex was precipitated by incubating with
20 ml of protein-A/G PLUS agarose (Santa Cruz Biotechnology)
over night at 4uC. The mixture was then centrifuged, and the
pellet was washed 5 times with lysis buffer. The pellet was
resuspended in 16Laemmli buffer, boiled, electrophoresesed on a
7.5% polyacrylamide gel and transferred to PVDF membrane for
immunobloting assay.
Animal and human research ethic statement
Animal research ethics approval for this study using primary
keratinocytes isolated from new born mouse skin for in vitro culture
and adult mouse skin materials was obtained from The University
of Queensland Animal Ethics Committee (AEC No: CICR/196/
06/CICR). Human research ethic approval for this study using
human skin materials was obtained from Medical Research Ethics
committee of The University of Queensland (MEC No: MED/
PAH/04/NHMRC/UNIQUE). The primary human keratino-
cytes used for supplementary experiments in this study were kindly
provided by Associate Professor Nicholas A. Saunders at the
Diamantina Institute for Cancer Immunology and Metabolic
Medicine, The University of Queensland. Dr. Saunders had the
consent from the donors. Therefore, The Medical Research Ethics
committee of The University of Queensland waived the need for
consent from the donors for using the human foreskin to prepare
primary human keratinocytes.
Results
A spectrin-like cytoskeleton is organized in
differentiating keratinocytes in vitro
We previously confirmed progressive differentiation of primary
mouse keratinocytes cultured in vitro in low calcium medium at a
specific cell density from day 1 to day 7 [19,22]. Here, we first
examined the spectrin-like cytoskeleton and spectrin expression in
primary mouse and human keratinocyte cultures over a period of
seven days. The majority of primary mouse and human
keratinocytes grown in vitro at D1 failed to show spectrin staining
(Fig. 1A; Supporting information Fig. S1), but punctate spectrin
staining was evident in a few cells (Fig. 1A; Supporting information
Fig. S1), indicating weak expression of spectrin protein that
appeared to be intracytoplasmic. By D4, 30–50% of keratinocytes
showed staining of spectrin, which was associated with the nuclei
(Fig. 1A). By D7, 60–80% of the cultured keratinocytes stained
strongly for spectrin and had a well organized spectrin-like
cytoskeleton across the plasma membrane (Fig. 1A; Supporting
information Fig. S1). In D7 keratinocytes, spectrin was co-
expressed with the keratinocyte differentiation marker involucrin
(Fig. 1B). Immunofluorescence staining showed a co-localization of
spectrin and actin in D7 keratinocytes (Fig. 1C). Immunoblotting
confirmed further that expression of spectrin in both primary
mouse and human keratinocyte cultures was significantly up-
regulated with increasing culture time, coincident with increased
expression of involucrin (Supporting information Fig. S2). The
antibody used was raised to detect both a- and b- spectrins (240
and 220 kDa), but Immunoblotting showed only one spectrin
band of 240 kDa (Fig. 1D). Using antibodies specific to a1 spectrin
and b1 spectrin, it was confirmed that the spectrin band detected
corresponds to a spectrin at 240 kDa (Data not shown).
Furthermore, b1 specific spectrin antibody confirmed that the
faint band observed at approximately 78 kDa (Fig. 1D), probably
corresponded to an alternative form of b spectrin (SPTBN4 with
678 amino acids; http://biogps.gnf.org). All of the D1 cultured
keratinocytes showed strong tubulin staining and a well organized
tubulin cytoskeleton (Fig. 1A; Supplementary Figure S2B), but by
D7, tubulin staining was reduced and the tubulin cytoskeleton was
not well organized (Fig. 1A; Supporting information Fig. S1).
Expression of tubulin was down-regulated (Fig. 1D; Supplemen-
tary Figure S2A and S3B). This is consistent with previous data
showing that undifferentiated keratinocytes contained numerous
microtubules radiating from a centrosomal organization center
(MTOC) [23], while differentiating keratinocytes displayed an
altered cytoskeleton including rearranged microtubules [23,24].
These results suggest that spectrin and tubulin are inversely related
in their expression and organization in cytoskeletal structures
during keratinocyte differentiation.
Spectrin-like cytoskeleton is predominantly organized in
granular and cornified layers of the epidermis
To investigate this phenomenon in greater depth, we examined
the spectrin-like and microtubule cytoskeletons in both mouse
and human skin using immunofluorescence microscopy (Fig. 2A–
F; Supporting information Fig. S3, S4, S5). Strong staining of
spectrin protein was observed in granular keratinocytes and
cornified envelope where nuclei are being lost [25]. This is
different from a previous observation that spectrin-like proteins
are localized to the peripheral cytoplasm of basal keratinocytes
[26]. Spectrin staining was also observed in papillae of mouse
dermis and in superficial differentiated keratinocytes in deeper
hair follicles of human epidermis (Fig. 2A–F; Supporting
information Fig. S3). In contrast, tubulin stained more extensively
throughout the dermis and epidermis including the basal,
suprabasal and granular keratinocytes, except for the cornified
envelope (Fig. 2A–B; Supporting information Fig. S3). No
staining of the spectrin-like cytoskeleton was observed in basal
keratinocytes of the proliferative zone, which showed typical
staining of basal cell keratin K14 (Fig. 2C–D; Supporting
information Fig. S4), consistent with previous data showing that
K14 is expressed exclusively in the innermost mitotically active
basal cell layer in normal skin [27]. Staining patterns of spectrin-
like cytoskeleton in mice and human skin were closely associated
with involucrin (Fig. 2E–F; Supporting information Fig. S5). Our
data reveal a characteristic feature of the spectrin-like cytoskel-
eton predominantly organized in granular and cornified layers of
the epidermis, which is associated with stratified epithelia in
mouse and human skin.
Two microfilament inhibitors disrupt the spectrin-like
cytoskeleton in keratinocytes
To investigate the possible mechanism that may regulate
assembly of the spectrin-like cytoskeleton associated with kerati-
nocyte differentiation, we used different cytoskeletal inhibitors to
treat the primary mouse keratinocytes in culture. We first treated
the primary mouse keratinocytes, grown in medium for five days,
with two anti-mitotic drugs: colchicine (Col) and nocodazole (Noc)
for 12 h to investigate the possible mechanism that regulates
organization of the spectrin-like cytoskeleton during keratinocyte
differentiation. These two drugs had little effect on the spectrin-
like cytoskeleton in keratinocytes (Fig. 3A–C). Western blot
analysis confirmed that neither Col nor Noc altered spectrin
expression (Fig. 3D). Only Col markedly reduced tubulin
expression (Fig. 3D). The results suggest that polymerization and
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PLoS ONE | www.plosone.org 3 December 2011 | Volume 6 | Issue 12 | e28267Figure 1. Spectrin-like cytoskeleton and spectrin expression in primary mouse keratinocyte cultures up to seven days. (A).
Keratinocytes cultured for 1 (D1), 4 (D4) and 7 (D7) days were compared for spectrin-like cytoskeleton (Green) and tubulin cytoskeleton (Red) by
immunofluorescence staining. (B). Immunofluorescence staining for spectrin (Green) and involucrin a terminal differentiation marker (Red) in D7
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associated with keratinocyte differentiation are independent of cell
division because keratinocytes stop dividing after entering a
differentiation program [14,28].
We next examined whether actin filament inhibitors could affect
organization of the spectrin-like cytoskeleton and protein expres-
sion in keratinocytes. Three actin filament inhibitors: Cytochalasin
B (CB), staurosporine (STS) and latrunculin B [21] were
Figure 2. Organization of spectrin-like cytoskeleton, microtubules, K14 and involucrin filaments in mouse and human skin. (A and
B). Sections of mouse and human skin were immunostained as indicated for spectrin(Green) and tubulin (Red). (C and D). Sections of mouse and
human skin were immunostained as indicated for spectrin (Green) and K14 (Red). (E and F). Sections of mouse and human skin were immunostained
as indicated for spectrin (Green) and involucrin (Red). Nuclei (Blue) from the same fields were counterstained with DAPI. Scale bars are 30 mm. The
mouse has a narrow staining skin epidermis while that in human shows greater depth of staining.
doi:10.1371/journal.pone.0028267.g002
cultured keratinocytes. (C). Immunofluorescence staining for spectrin (Green) and actin (Red) in D7 cultured keratinocytes. Nuclei (Blue) from the
same field were counterstained with 49,69-diamidino -2-phenylindole (DAPI). Scale bars are 15 mmi n( A) and in (B) and 20 mmi n( C). (D). Western blot
analysis for spectrin and tubulin in primary keratinocytes cultured for a period of 1–7 days. Results are representative of three individual experiments.
doi:10.1371/journal.pone.0028267.g001
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PLoS ONE | www.plosone.org 5 December 2011 | Volume 6 | Issue 12 | e28267Figure 3. Disruption of the spectrin-like cytoskeleton in primary mouse keratinocytes by cell division and microfilament inhibitors.
A), B) and C). Keratinocytes treated with cell division inhibitors were compared for organization of spectrin cytoskeleton (Green) and tubulin (Red) in
primary keratinocytes by immune-fluorescence staining. Nuclei (Blue) from the same field were counterstained with DAPI. Scale bars are 20 mm. D)
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inhibitors were severely disrupted (Supporting information Fig.
S6). Both STS and Lat treatments of keratinocytes not only
disrupted actin filaments, but also dissolved the spectrin-like
cytoskeleton over the cell membrane, resulting in curved and short
spectrin filaments centralized on the nuclear surface (Fig. 3F–H).
However, CB treatment did not affect organization of the spectrin-
like cytoskeleton (Fig. 3H). In contrast, immunofluorescence
staining for tubulin cytoskeleton was clearly stronger in all three
actin inhibitor-treated keratinocytes (Figure 3F–H) than in
untreated cells (Figure 3A). Western blots showed that the levels
of spectrin protein were slightly reduced in keratinocytes treated
with CB and STS, but markedly reduced in Lat-treated
keratinocytes (Fig. 3E). The levels of tubulin in keratinocytes
treated with the actin polymerization inhibitors were not affected
(Fig. 3E). Immunoblotting did not show any evidence of spectrin
degradation (Supporting information Fig. S7). These data
demonstrate that both STS and Lat treatments caused qualitative
and quantitative changes of the spectrin-like cytoskeleton, which
can explain abnormalities of cell shape in keratinocytes, similar to
previous studies in erythrocytes [29,30].
Disruption of the spectrin-like cytoskeleton by actin
filament inhibitors is accompanied by phosphorylation of
PKCd
(Thr505)
Keratinocytes express the five major isoforms of protein kinase
C (PKC) [31], but PKCa and PKCd are the most abundant
isoforms, regulating proliferation and differentiation of these cells
[32,33,34,35,36]. Thus, we determined whether the three actin
filament inhibitors affected expression of PKCa and PKCd in
keratinocytes. Immunoblotting analysis failed to reveal any effect
of the three inhibitors on expression of PKCa in keratinocytes
(Supporting information Fig. S8). Furthermore, phosphorylation
of PKCa on Ser657, or Thr638/641 was not detected in STS- and
Lat-treated keratinocytes (data not shown). The two anti-mitotic
drugs (Col and Noc) had little or no effect on expression of PKCd
(Fig. 4A, left hand panel). Expression of PKCd appeared to be
reduced in both STS and Lat–treated keratinocytes, compared
with that in control and CB-treated keratinocytes (Fig. 5A, right
hand panel). Both STS and LAT markedly enhanced phosphor-
ylation of this protein on Thr505 (P-PKCd
(Thr505); Fig. 4A, right
hand panel), but CB had no effect. Phosphorylation at this site
increases the activity of PKCd by up to 80-fold [37]. The mitotic
inhibitors (Col and Noc) did not alter expression of P-PKCd
(Thr505)
above basal levels (Fig. 4A, left hand panel). Immunofluorescence
staining revealed a PKCd cytoskeleton distribution in untreated
keratinocytes, similar to that of the spectrin-like cytoskeleton
(Fig. 4B). Treatment with STS and Lat resulted in dissolution of
the spectrin-like cytoskeleton and abnormal re-organization of
both spectrin and PKCd in the cytoplasm and nucleus (Fig. 4B). It
has been reported that both spectrin and PKCd bind actin and
predominantly localize to the actin filaments [38,39]. Latrunculin
decreases PKCd binding to actin by directly binding to it and
thereby preventing its polymerization [38,40]. Consistent with the
increased phosphorylation of PKCd observed by immunoblotting
after STS and LAT treatments, intense staining for P-
PKCd
(Thr505) was observed in keratinocytes treated with these
agents (Fig. 4C). In addition, spectrin staining was distinctly
diminished under these conditions (Fig. 4C). The results indicate
that phosphorylation of PKCd
(Thr505) is tightly associated with
disruption of the spectrin-like cytoskeleton in keratinocytes.
Inhibition of PKCd activation by rottlerin prevents
disruption of the spectrin cytoskeleton
We determined further whether phosphorylation of PKCd on
Thr505 disrupts the spectrin-like cytoskeleton and inhibits
expression of spectrin protein, using rottlerin (RT), a specific
inhibitor of PKCd phosphorylation in different mammalian cells
[41]. Co-treatment with STS and RT or Lat and RT provided a
reversal of the morphological changes of the cells (Fig. 5A), and
also prevented disruption of the spectrin-like cytoskeleton
associated with keratinocytes differentiation (Fig. 5B). Concomi-
tant with this RT also prevented the decrease in spectrin (Fig. 5C).
Under these conditions RT reduced PKCd phosphorylation in
both STS and especially Lat treated cultures (Fig. 5C). Further-
more, co-treatments of STS and RT or Lat and RT scarcely
affected expression of pan-PKC and PKCa (Data not shown). The
results support further an important role for phosphorylation of
PKCd
(Thr505), inhibiting spectrin expression and disrupting the
organization of the spectrin-like cytoskeleton in differentiating
keratinocytes.
Phosphorylation of PKCd appears not to directly disrupt
organization of spectrin-like cytoskeleton
We determined whether P-PKCd
(Thr505) interacted with spec-
trin protein to directly disrupt the spectrin-like cytoskeleton in
differentiating keratinocytes. Immunoprecipitation with antibodies
against involucrin, tubulin, pan-PKC and PKCa did not
precipitate spectrin (Supporting information Fig. S9), indicating
that the four proteins examined do not interact with spectrin,
suggesting further that they are not directly involved in re-
organization of the spectrin-like cytoskeleton. Anti-actin antibody
precipitated spectrin, but neither anti-PKCd, P-PKCd
(Thr505), nor
IF-c (as a negative control) antibody precipitated spectrin (Fig. 6).
Both anti-spectrin and actin antibodies, but not P-PKCd
(Thr505)
and IF-c antibodies, precipitated PKCd in cell lysates (Fig. 6).
None of the four antibodies could precipitate P-PKC
(Thr505)
(Fig. 6). Thus, it appears that activation of PKCd on Thr505 does
not directly disrupt organization of the spectrin-like cytoskeleton.
Adducin, a potential substrate for PKCd and P-
PKCd
(Thr505) in disruption of the spectrin-like cytoskeleton
Previous studies have reported that adducin, a cytoskeletal
protein, is localized at spectrin–actin junctions to regulate
assembly of spectrin-actin complexes in erythrocyte membrane
skeletons [42] and PKC phosphorylates adducin and regulates its
function [43]. Thus, we determined whether adducin and
phosphorylated-adducin on Ser662 (P-adducin
(Ser662)) were co-
expressed with spectrin, actin, PKCd and P-PKCd in keratino-
cytes. Immunofluorescence staining showed that adducin is
consistently co-expressed with spectrin, actin and PKCd in
differentiating keratinocytes (Fig. 7A, B). But, co-expression of
adducin with P-PKCd
(Thr505) was only observed in Lat-treated
keratinocytes (Fig. 7B). Immunofluorescence staining showed co-
expression of P-adducin with spectrin, actin, PKCd and P-
PKCd
(Thr505) in Lat-treated keratinocytes (Fig. 8A, B). These data
reveal that adducin is expressed in differentiating keratinocytes
and E). Western blot analysis for spectrin, involucrin and tubulin in primary mouse keratinocytes treated with cell division and microfilament
inhibitors. F), G) and H). Keratinocytes treated with microfilament inhibitors were compared for organization of spectrin cytoskeleton (Green) and
tubulin (Red) by immune-fluorescence staining. Nuclei (Blue) from the same field were counterstained with DAPI. Scale bars are 20 mm.
doi:10.1371/journal.pone.0028267.g003
Spectrin in Keratinocyte
PLoS ONE | www.plosone.org 7 December 2011 | Volume 6 | Issue 12 | e28267Figure 4. Differential effects of cell division and microfilament inhibitors on expression of PKCd and phosphorylated-PKCd
(Thr505)
(labelled as P-PKCd) in primary keratinocytes. Primary mouse keratinocytes, after culturing for five days, were treated with the five inhibitors for
12 h, respectively. (A) Western blot analysis for expression of PKCd (upper panel) and P-PKCd (lower panel)after treatment with different inhibitors.
Actin was examined as loading control. (B). Control and STS- and Lat-treated keratinocytes were triple-stained for spectrin (Green), PKCd (Red) and
nuclei (Blue). Scale bars are 15 mm. (C). Control and STS- and Lat-treated keratinocytes were triple-stained for spectrin (Green), P-PKCd (Red) and
nuclei (Blue). Arrows point to cells exhibiting strong phosphorylation of PKCd
(Thr505) and weak expression of spectrin. Scale bars are 20 mm.
doi:10.1371/journal.pone.0028267.g004
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PLoS ONE | www.plosone.org 8 December 2011 | Volume 6 | Issue 12 | e28267Figure 5. Rottlerin (RT) inhibited expression of P-PKCd caused by STS and Lat in primary mouse keratinocytes. Primary mouse
keratinocytes after culturing for five days were treated with RT, CB, CB+RT, STS, STS+RT, Lat and Lat+RT for 12 h, respectively. The keratinocytes were
then recorded for their morphology and harvested for analysis of expression of spectrin, PKCd and P-PKCd.2mm RT was used. (A). Cell morphology
comparison between control and inhibitor-treated keratinocytes. (B). Cells were compared for organization of spectrin-like cytoskeleton (Green) and
tubulin cytoskeleton (Red) in primary mouse keratinocytes treated with control, RT, Lat and Lat+RT by immunofluorescence staining. Scale bars are
20 mm. (C). Western blotting analysis for expression of spectrin, PKCd and P-PKCd. Actin was examined as loading control.
doi:10.1371/journal.pone.0028267.g005
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the spectrin-actin complex. To establish a role for adducin
phosphorylation in this process, we investigated the effect of
disruption of the spectrin-like cytoskeleton in the presence and
absence of the PKCd inhibitor RT. Under these conditions RT
had a marked inhibitory effect on expression of P-adducin
(Ser662)
(Fig. 9A). Immunoblotting analysis of immunoprecipitates showed
further that both adducin and P-adducin
(Ser662) interacted with
PKCd, P-PKCd
(Thr505), spectrin and actin (Fig. 9B,C). The strong
interaction of adducin and P-adducin
(Ser662) with PKCd and P-
PKCd
(Thr505) confirms that adducin is a potential substrate for
PKCd and P-PKCd
(Thr505) in disruption of the spectrin-like
cytoskeleton in keratinocytes.
We next examined whether and how PKCd, P-PKCd
(Thr505),
adducin and p-adducin
(Ser662) were expressed in both D1 and D7
mouse primary keratinocyte cultures (Fig. 10A,B). Immunoblotting
showed clearly that PKCd was primarily expressed in D7
keratinocytes while P-PKCd
(Thr505) was expressed in D1 keratino-
cytes (Fig. 10A). Immunoblotting showed further that adducin was
largely expressed in D7 keratinocytes, with three bands corre-
sponding to b-adducin at 94 kDa and a-adducin 74 kDa
(Fig. 10B). Two bands of phosphorylated adducin were detected,
corresponding toP-b-adducin
(Ser662) at 97 kDa and P-a-adducin
(Ser726)
at 75 kDa in D1 keratinocytes (Fig. 10B). The data reveal two
points: 1). both PKCd and adducin have a similar expression
pattern to that of spectrin in keratinocytes associated with cell
differentiation and 2). expression of P-PKCd
(Thr505) is coincident
with that of P-b-adducin
(Ser662) in keratinocytes associated with cell
proliferation.
Knock-down of endogenous adducin disrupts spectrin-
like cytoskeleton
We determined whether knock-down of endogenous adducin in
keratinocytes could affect expression of, spectrin, PKCd and P-
PKCd
(Thr505) and lead to disruption of the spectrin-like cytoskel-
eton in D7 keratinocytes. We observed that b-adducin siRNAs-
transfected keratinocytes had a distinctly different cell morphology
from the control siRNA-transfected keratinocytes, with evidence of
enhanced keratinocyte proliferation(Supporting information Fig.
S10). Immunoblotting showed that transfection of the b-adducin
siRNA resulted not only in significant reduction of adducin, but
also of spectrin and PKCd (Fig. 11A). The results confirm that
expression of adducin was associated with that of spectrin and
PKCd in keratinocytes.
We next examined organization of the spectrin-like cytoskeleton
compared with distribution of adducin, P-adducin
(Ser662), PKCd
and, P-PKCd
(Thr505) in both control siRNA- and b-adducin
siRNA-transfected keratinocytes by immunofluorescence staining.
Control siRNA had no effects on organization of the spectrin-like
cytoskeleton and the cytoskeletal organization as well as the
distribution of both adducin and PKCd in keratinocytes (Fig. 11B).
In contrast, b-adducin siRNA transfection severely disrupted not
only the organization of the spectrin-like cytoskeleton, but also the
cytoskeletal organization and distribution of both PKCd and
adducin (Fig. 11B). The results provide evidence that organization
of the spectrin-like cytoskeleton and spectrin expression are firmly
dependent on either expression of endogenous PKCd and adducin




Primary mouse and human epidermal keratinocytes grown in
vitro can reproduce the general features of differentiation seen in
suprabasal and granular cells of stratified epidermis (Fuchs and
Green, 1980; Pillai et al, 1990). During keratinocyte differentiation
and stratification of the epidermis, terminal differentiation markers
including involucrin, transglutaminase and several keratins are
expressed and assembled into intermediate filaments. Spectrin as a
major plasma membrane-bond protein has been reported in the
keratinocytes of human skin [17,18,26]. However, the studies
showed different characteristics of the spectrin expressed in human
skin. Different from the strong staining of the spectrin protein in
differentiated keratinocytes in the granular and cornified layers of
the human epidermis [17], Shimizu et al. observed that the
spectrin proteins were only localized to the peripheral cytoplasm of
the keratinocytes in the basal layer [26]. Tuominen et al. found
that keratinocytes in all layers of the human skin expressed
spectrin. While basal keratinocytes contained intracytoplasmic
spectrin, suprabasal keratinocytes showed membrane-bound
spectrin [18]. In fact, both cornifed and granular layers of human
skin showed the strongest staining of the spectrin and well
organized spectrin-like cytoskeleton. Here, we investigated expres-
sion of spectrin and its cytoskeletal organization in both mouse and
human keratinocytes in vitro and in vivo. The results from the in vitro
Figure 6. Immunoprecipitation assay of total proteins prepared from primary mouse keratinocyte cultures with the indicated
antibodies. Primary mouse keratinocytes cultured for five days were treated with or without Lat for 12 h. The keratinocytes were then harvested for
preparing protein samples. Protein samples were immunoprecipitated with the five indicated antibodies and analyzed by immunoblotting assay.
doi:10.1371/journal.pone.0028267.g006
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assembly of the spectrin-like cytoskeleton in primary keratinocytes
cultures are tightly associated with keratinocyte differentiation,
consistent with previous observations in erythrocytes [44].
Moreover, the observed changes of the spectrin-like cytoskeleton
as a supportive membrane skeleton may reflect the membrane
dynamics of the primary keratinocytes during cell differentiation.
In epidermal keratinocytes, the membrane skeletal proteins play
functional roles to maintain the polarity of membrane proteins by
connecting them to the cytoskeleton, to regulate cell-cell
interdigitations and stabilize newly synthesized cell membranes
before elaboration of cell-cell interdigitations [26]. The spectrin-
like cytoskeleton is thus an active material that can adapt its
mechanics and perform structural tasks in mammalian epidermis.
Furthermore, it is possible that the organized spectrin-like
cytoskeleton can serve as an early end point for the development
of skin.
Spectrin comprises a (240 kDa) and b (220 kDa) subunits,
forming an elongated (ab)2 tetramer in erythrocytes [1], but the
full length proteins of the two subunits are not required to form the
spectrin/adducin/actin complex [45]. Spectrin has been previ-
ously detected in keratinocytes [17,18,26,46,47], but it is unclear
whether both a and b spectrins are expressed in full-length form to
assemble into the spectrin-like cytoskeleton. In this study, we
detected full-length a spectrin, but only a smaller size b spectrin at
78 kDa. The lower molecular size of b spectrin corresponds to an
alternative N-terminal form (SPTBN4 with 678 amino acids;
http://biogps.gnf.org). We have not established why only a short
form of the b spectrin is expressed in differentiating keratinocytes,
but our results are consistent with previous quantitative evidence
Figure 7. Co-expression of adducin with spectrin (A), actin (A), PKCd (B) and P-PKCd (B) in primary keratinocytes with or without Lat
treatment. Control and Lat-treated keratinocytes were triple stained for adducin (Green), spectrin, actin, PKCd and P-PKCd (Red) and nuclei (Blue).
Scale bars are 20 mm.
doi:10.1371/journal.pone.0028267.g007
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a-helical domains are required for optimal participation of
spectrin in spectrin/adducin/actin complexes [45].
We showed here that the spectrin-like cytoskeleton in the
epidermis of mouse and human skin is prominently localized to
the cornified and granular layers. The cornified envelope is a
hallmark of terminal differentiation of keratinocytes, which is a
highly insoluble and extremely tough structure formed beneath the
cell membrane and is continuously replenished as granular
keratinocytes move outwards and are sloughed from the skin
surface [16]. The main function of the cornified envelope is to
provide mammalian skin with a protective barrier that excludes
harmful microbes and retains body fluids [14,48]. The data
presented here suggest that spectrin protein is a major structural
component of granular keratinocytes and the cornified envelope. A
previous report shows that non-erythrocyte spectrin is involved in
linking intermediate filaments to the plasma membrane [49]. This
suggeststhat spectrinmaybe across-linkingsubstrateforinteraction
with multiple proteins to enhance the structural integrity of the
epidermis and to generate the polarized morphology of epithelial
cells [50,51]. Thus, the spectrin-like cytoskeleton, prominently
organized inthecornifiedenvelope,maybe involved inmaintaining
the cellular integrity and stratification of squamous epithelium in
mouse and human skins and contribute to the barrier organization
and function of the epidermis, which is fundamental to the
physiology and development of epithelial cells [52].
Figure 8. Co-expression of phosphorylated-adducin (P-Addu) with spectrin (A), actin (A), PKCd (B) and P-PKCd (B) in primary
keratinocytes with or without Lat treatment. Control and Lat-treated keratinocytes were triple stained for P-Adducin (Green), spectrin, actin,
PKCd and P-PKCd PKCd (Red) and nuclei (Blue). Scale bars are 20 mm.
doi:10.1371/journal.pone.0028267.g008
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cytoskeletal structures including the nuclear lamina and vimentin
containing intermediate filaments is induced during mitosis [53].
Tubulin phosphorylation is related to tubulin disassembly and
architectural integrity of microtubules during the cell cycle [54].
According to the published studies in erythrocytes and other cells,
spectrin phosphorylation occurs mainly on b spectrin [55,56,57].
Thus, in the present study, it is unlikely that the altered
organization of the spectrin-like cytoskeleton observed in actin
inhibitor-treated keratinocytes is due to phosphorylation of
spectrin because no extra spectrin band was shown in inhibitor-
treated keratinocytes. Furthermore, the reported phosphorylation
of the cytoskeletal components and their functional changes are
associated with cell cycle progression. CHO cell spectrin is
phosphorylated exclusively on the b subunit in both interphase
and mitotic cells [58]. Our results clearly indicate that spectrin
expression and its cytoskeletal organization are tightly associated
with keratinocyte differentiation and these cells exit the cell cycle
once they enter the terminal differentiation program.
Treatment with the actin filament inhibitors (CB, STS and Lat)
produced different effects on the organizations of microfilaments,
spectrin-like cytoskeleton and PKCd in keratinocytes. CB did not
affect organizations of the spectrin-like cytoskeleton and PKCd in
keratinocytes although it disrupted microfilaments. Why CB does
not disrupt organization of the spectrin-like cytoskeleton in
keratinocytes can be explained by previous results [59,60]. CB
induced depolymerization of the endoplasmic reticulum (ER) -
associated F-actin, but a-spectrin remained colocalized with the ER
because it is bound to the ER membrane in Drosophila [59]. In the
cytoskeletal ATPase fraction of human erythrocyte CB inhibited
actin ATPase activity to polymerize G-actin to form shorter
filaments, but did not affect spectrin polymerization because
spectrin has the same elasticity as the underlying spectrin/
dystrophin network and does not have the same cytoskeletal
ATPase [60]. Both STS and Lat have been reported to be inhibitors
of PKC, resulting in simultaneous redistribution and centralization
of both spectrinand PKCd and reduced expression of these proteins
in differentiating keratinocytes [61,62,63]. Spectrin has been
reported to colocalize with PKCb II in T lymphocytes [64]. But,
to date, no study has been reported showing that spectrin is co-
expressed with any isoform of PKC in keratinocytes, although it has
beenreportedthatkeratinocytesexpresstwomajorisoformsofPKC
(PKCa and PKCd) [65]. Previous studies have well established that
the novel PKC isoforms stimulate keratinocyte differentiation
[66,67]. PKCd is the most potent of these activators [36,68] and
its activity can be inhibited by a specfic PKCd inhibitor, rottlerin
[65,67,69], we revealed here that PKCd plays a regulatory role in
organization of the spectrin-like cytoskeleton in keratinocytes.
Figure 9. Immunoprecipitation assay of total proteins prepared from primary mouse keratinocyte cultures with the indicated
antibodies. Primary mouse keratinocytes cultured for five days were treated with Latrunculin or with Latrunculin+Rottlerin for 12 h. Then the
keratinocytes were collected for protein preparations. Protein samples were immunoprecipitated with six antibodies as indicated, respectively. (A).
Proteins immunoprecipitated by antibodies against adducin and p-adducin were analyzed by immunoblotting using adducin and p-adducin
antibodies as indicated. (B). Proteins immunoprecipitated with antibodies against PKCd and p-PKCd were analyzed by immunoblotting using adducin
and p-adducin antibodies as indicated. (C). Proteins immunoprecipitated by antibodies against spectrin and actin were analyzed by immunoblotting
using adducin and p-adducin antibodies as indicated. Note: IFNc antibody was used as a control antibody for the IP experiments. As shown in Fig. 6,
the Spectrin, PKCd and P-PKCd antibodies did not across react with the immunoprecipitates by IFNc antibody. Neither adducin nor phosphorylated
adducin antibody had a cross reaction with IFNc antibody (data not shown).
doi:10.1371/journal.pone.0028267.g009
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inhibitors was also accompanied by markedly increased levels of
PKCd phosphorylation on Thr505. Previous data have shown that
phosphorylation on this site increases the activity of this protein
[37]. Thus it seems likely that PKCd activation is causally linked to
the re-organization of the spectrin-like cytoskeleton in keratino-
cytes. Under these conditions increased phosphorylation of
PKCd
(Thr505) was also observed. Further evidence for this was
provided by inhibition of both PKCd phosphorylation and
disruption of the spectrin-like cytoskeleton by the PKCd specific
inhibitor rottlerin. This agent has previously been shown to be
anti-proliferative, inhibiting cell cycle progression and enhancing
apoptosis [70]. Since there is no evidence that PKCd phosphor-
ylates spectrin or actin it seemed likely that the disassembly of
spectrin-actin complexes would be mediated through an interme-
diate substrate. A good candidate for this role is adducin, a protein
that preferentially recruits spectrin to the ends of growing actin
filaments to stabilize the complex [71,72]. Adducin is localized at
spectrin–actin junctions in erythrocyte membrane skeletons and
colocalizes with spectrin at sites of cell–cell contact in epithelial
cells [46,71,73]. We have shown here that adducin is involved in
the formation of a spectrin-actin lattice in keratinocytes. Previous
results have only reported that it is present in the epidermis [46].
PKC phosphorylation of native or recombinant adducin inhibited
F-actin capping and prevented the recruitment of spectrin to actin
filaments [72]. They also demonstrated that PKC phosphorylated
adducin in neuronal dendritic spines that respond to external
stimuli by changing the morphology and re-organization of
cytoskeletal structures. But it was unclear whether a specific form
of PKC was phosphorylated. Phosphorylation of adducin also
occurs during platelet activation causing its dissociation from the
spectrin-actin complex which in turn leads to release of spectrin
from actin [74]. This leads to exposure of actin filaments which
may contribute to the platelet shape change on activation. We
have demonstrated here disruption of the spectrin-like cytoskele-
ton by one of the actin filament inhibitors latrunculin. Further-
more, the PKCd inhibitor rottlerin prevented latrunculin-induced
phosphorylation of adducin and the accompanying disruption of
the spectrin-like cytoskeleton. Previous reports on the phosphor-
ylation of adducin in hippocampal neurons, platelets, growth
cones of axons and in erythrocytes provide evidence for an
involvement of PKC but none of these identified the specific PKC
Figure 10. Western blot analysis for expression of (A) PKCd and phosphorylated PKCd
(Thr505) (P- PKCd
(Thr505)) and (B) adducin and
phosphorylated adducin
(Ser662) (P-adducin
(Ser662)) in primary mouse keratinocytes cultured for a period of one (D1) to seven (D7)
days. Results are representative of two individual experiments.
doi:10.1371/journal.pone.0028267.g010
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contributes to this process. However, it is likely that this signaling is
complex involving more than one phosphorylation site on
adducin, more than one protein kinase and participation of
substrates in addition to adducin. We showed here that adducin is
phosphorylated on ser662 but two other PKC-dependent
phosphorylation events (ser716 and ser726) on adducin inhibit
its activity in promoting spectrin-actin complex formation [72].
While the outcome may be the same in the different systems,
disruption of the spectrin-actin complex, this appears to be
achieved by adducin phosphorylation at different sites in response
to different stimuli. Rho-kinase has also been shown to
Figure 11. Effects of b-adducin specific siRNA on expression of spectrin, adducin, P-adducin
(Ser662), PKCd and P-PKCd
(Thr505) in
primary mouse keratinocytes. Primary mouse keratinocytes, after culturing for five days, were transfected with either non-targeting siRNA
(control siRNA) or b-adducin specific siRNA (Addu-siRNA), respectively. The siRNA-transfected keratinocytes at 48 h post-transfection were collected
for both western blotting analysis and immunofluorescence labelling. (A). Western blot analysis for expression of spectrin, adducin, P-adducin
(Ser662),
PKCd and P-PKCd
(Thr505). Actin was used as a loading control. Results are representative of two separate transfection experiments, with 6 replicates in
one transfection experiment. (B). The keratinocytes transfected with control siRNA and adducin siRNA were triple-stained for spectrin (Green), P-
adducin
(Ser662), adducin, PKCd and P-PKCd
(Thr505) (Red) and nuclei (Blue). Scale bars are shown in the images.
doi:10.1371/journal.pone.0028267.g011
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opposite effect to PKC-dependent phosphorylation in that it
positively regulates the association of adducin with the spectrin-
actin cytoskeleton [77]. A variety of other proteins including
protein 4.1R, band 3/ankyrin complex, tropimodulin and
tropomyosin are also involved in the assembly. Furthermore,
knock-down of endogenous adducin by b-adducin siRNA
disrupted the spectrin-like cytoskeleton and reduced expression
of spectrin in keratinocytes. Although the adducin-b siRNA
significantly reduced expression of both adducin and PKCd and
disrupted their cytoskeletal distributions, it did not activate
adducin on Ser662 and PKCd on Thr505 in keratinocytes. Thus,
it appears that adducin plays different roles in mediating the
organization of the spectrin-like cytoskeleton in keratinocytes. The
phosphorylation event may not be the only means of activating
PKCd since Zhu et al (2008) have shown that tyrosine
phosphorylation on Y311 as well as on other secondary sites
influence the ability of PKCd to increase expression of involucrin.
Nevertheless, the organization of the spectrin-like cytoskeleton and
spectrin expression in differentiating keratinocytes are tightly
associated with adducin expression and its physiological status.
Adducin acts through spectrin to stabilize epithelial junctions and
to regulate global properties of the membrane of keratinocytes.
In summary, we show for the first time that the spectrin-like
cytoskeleton assembled in mouse and human keratinocytes is
dynamically associated with cell differentiation. The spectrin-like
cytoskeleton organized in differentiating keratinocytes and its
predominantly regional localization to the cornified layer of the
epidermis is essential for healthy human skin. The spectrin-like
cytoskeleton interacts with actin filaments to form a ternary
complex to support the keratinocyte plasma membrane and the
integrity of the complex is dependent on PKCd activity, adducin
phosphorylation status and cell differentiation. Both activation of
PKCd (Thr505) by microfilament inhibitors and knock-down of
endogenous adducin by adducin specific siRNA remodel the
spectrin-actin ternary complex. The results have important
implications for the spectrin-like cytoskeleton and its potential as
a model system for studying the cellular integrity and stratification
of keratinocytes during differentiation, the mechanisms that
regulate skin development and the barrier organization and
function of the epidermis.
Supplementary Material
Total 10 supplementary figures include results on spectrin
expression and cytoskeleton in human primary keratinocytes, staining
of spectrin, actin, tubulin, K14 and involucrin in both mouse and
human skin sections and the results from different experiments.
Supporting Information
Figure S1 Organization of spectrin-like cytoskeleton in primary
human keratinocytes in vitro cultured for seven days. Cells were
compared for organization of spectrin-like and microtubule
cytoskeleton in primary keratinocyte cultures for D1 and D7 by
immunofluorescence staining. Scale bars are 20 mm.
(DOC)
Figure S2 Expression of spectrin in primary mouse and human
keratinocytes in vitro cultured for seven days. (A). Western blotting
analysis of spectrin, involucrin and actin in primary mouse
keratinocyte cultures for D1, D4 and D7.( B). Western blotting
analysis of spectrin, involucrin and tubulin in primary human
keratinocytes cultured for D1, D4 and D7. Forty micrograms of
protein samples were loaded for Western blotting analysis.
(DOC)
Figure S3 Spectrin-like and tubulin cytoskeletons in mouse and
human skin. Skin sections were immunostained as indicated for
spectrin (Green) and tubulin (Red). Nuclei (Blue) from the same
fields were counterstained with DAPI. Epidermis (E), dermis (D)
and hair follicles (H) of the skin sections are indicated.
(DOC)
Figure S4 Spectrin-like cytoskeleton and K14 filament in mouse
and human skins. Skin sections were immunostained as indicated
for spectrin (Green) and K14 (Red). Nuclei (Blue) from the same
fields were counterstained with DAPI.
(DOC)
Figure S5 Spectrin-like cytoskeleton and involucrin filament in
mouse and human skin. Skin sections were immunostained as
indicated for spectrin (Green) and involucrin (Red). Nuclei (Blue)
from the same fields were counterstained with DAPI.
(DOC)
Figure S6 Disruption of actin filaments in primary mouse
keratinocytes. Primary mouse keratinocytes after culturing for five
days were treated with microtubule and microfilament inhibitors
for 12 h, respectively. Both control and treated keratinocytes
were triple stained for actin (green), tubulin (red) and nuclei
(blue).
(DOC)
Figure S7 Effects of two microfilament inhibitors straurospor-
ine (STS) and latrunculin B [21] on spectrin expression in
primary mouse keratinocyte cultures. Primary mouse keratino-
cytes after culturing for five days were treated with three
inhibitors for 12 h, respectively. Western blot analysis showed
expression of spectrin, with the major band at 240 kDa and
another band approximately at 120 kDa. The two inhibitors did
not produce additional bands in keratinocytes except for reduced
expression of the spectrin.
(DOC)
Figure S8 Microfilament inhibitors (CB, STS and Lat) had no
effects on expression of PKCa in primary mouse keratinocytes.
Primary mouse keratinocytes after culturing for five days were
treated with three inhibitors for 12 h, respectively. Western blot
analysis for expression of PKCa, tubulin and actin.
(DOC)
Figure S9 Immunoprecipitation assay of total proteins prepared
from primary mouse keratinocyte cultures with the indicated
antibodies. Primary mouse keratinocytes cultured for five days
were treated with or without Latrunculin for 12 h. The
keratinocytes were then collected for protein preparations.
Proteins were immunoprecipitated with four antibodies as
indicated, respectively, and analyzed by immunoblotting assay
using five antibodies, respectively.
(DOC)
Figure S10 Morphology of control- and adducin b-siRNA
transfected mouse primary keratinocytes at 44 h post-transfection.
A, B, C and D representatives of four wells of the siRNA
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